Extendicare Inc. (EXETF)
OTCMKTS · Delayed Price · Currency is USD
14.79
+0.08 (0.54%)
Nov 26, 2025, 4:00 PM EST
Extendicare Market Cap
Extendicare has a market cap or net worth of $1.24 billion as of November 26, 2025. Its market cap has increased by 118.95% in one year.
Market Cap
1.24B
Enterprise Value
1.36B
Revenue
1.14B
Ranking
n/a
PE Ratio
19.02
Stock Price
$14.79
Market Cap Chart
Since May 15, 1997, Extendicare's market cap has increased from 973.52M to 1.24B, an increase of 27.62%. That is a compound annual growth rate of 0.86%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 26, 2025 | 1.24B | 101.48% |
| Dec 31, 2024 | 616.65M | 33.95% |
| Dec 29, 2023 | 460.35M | 11.06% |
| Dec 30, 2022 | 414.49M | -19.77% |
| Dec 31, 2021 | 516.64M | 10.73% |
| Dec 31, 2020 | 466.60M | -19.54% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 824.30M |
| Elite Pharmaceuticals | 555.46M |
| Glass House Brands | 520.88M |
| Tian'an Technology Group | 386.45M |
| CytoDyn | 384.62M |
| Northwest Biotherapeutics | 382.71M |
| American Oncology Network | 346.66M |
| Nika Pharmaceuticals | 311.89M |